Cite

Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancerAndreas Jordan is a manager and Uwe Gneveckow, Regina Scholz, and Norbert Waldöfner are employees at MagForce® Nanotechnologies GmbH, Berlin, Germany. The other authors declare that they do not have any affiliations that would lead to conflict of interest.

MLA

Manfred Johannsen, et al. “Thermotherapy Using Magnetic Nanoparticles Combined with External Radiation in an Orthotopic Rat Model of Prostate CancerAndreas Jordan Is a Manager and Uwe Gneveckow, Regina Scholz, and Norbert Waldöfner Are Employees at MagForce® Nanotechnologies GmbH, Berlin, Germany. The Other Authors Declare That They Do Not Have Any Affiliations That Would Lead to Conflict of Interest.” Prostate, vol. 66, no. 1, Jan. 2006, pp. 97–104. EBSCOhost, https://doi.org/10.1002/pros.20324.



APA

Manfred Johannsen, Burghard Thiesen, Uwe Gneveckow, Kasra Taymoorian, Norbert Waldöfner, Regina Scholz, Serdar Deger, Klaus Jung, Stefan A. Loening, & Andreas Jordan. (2006). Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancerAndreas Jordan is a manager and Uwe Gneveckow, Regina Scholz, and Norbert Waldöfner are employees at MagForce® Nanotechnologies GmbH, Berlin, Germany. The other authors declare that they do not have any affiliations that would lead to conflict of interest. Prostate, 66(1), 97–104. https://doi.org/10.1002/pros.20324



Chicago

Manfred Johannsen, Burghard Thiesen, Uwe Gneveckow, Kasra Taymoorian, Norbert Waldöfner, Regina Scholz, Serdar Deger, Klaus Jung, Stefan A. Loening, and Andreas Jordan. 2006. “Thermotherapy Using Magnetic Nanoparticles Combined with External Radiation in an Orthotopic Rat Model of Prostate CancerAndreas Jordan Is a Manager and Uwe Gneveckow, Regina Scholz, and Norbert Waldöfner Are Employees at MagForce® Nanotechnologies GmbH, Berlin, Germany. The Other Authors Declare That They Do Not Have Any Affiliations That Would Lead to Conflict of Interest.” Prostate 66 (1): 97–104. doi:10.1002/pros.20324.